Heron Therapeutics Inc.

NASDAQ: HRTX · Real-Time Price · USD
1.86
-0.02 (-1.06%)
At close: May 22, 2025, 3:59 PM
1.86
0.03%
After-hours: May 22, 2025, 07:48 PM EDT

Heron Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
C I N V A N T I Revenue 100.08M 94.87M 87.25M 73.51M 87.8M 132.2M
C I N V A N T I Revenue Growth +5.49% +8.74% +18.69% -16.28% -33.59% n/a
S U S T O L Revenue 14.14M 13.06M 10.23M 9.91M 800K 13.8M
S U S T O L Revenue Growth +8.31% +27.62% +3.19% +1139.38% -94.20% n/a
Z Y N R E L E F Revenue 25.55M 17.73M 10.2M 2.92M n/a n/a
Z Y N R E L E F Revenue Growth +44.11% +73.86% +248.70% n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 25.01M 23.2M 23.34M 27.52M 26.42M 23.62M 24.6M 36.44M 32.01M 26.7M 28.18M 32.12M 32.95M 34.37M 34.99M 33.16M 24.81M 28.06M 22M 25.41M 30.62M 30.29M 25.57M 33.42M 38.37M 28.7M 23.57M 20.74M 20.86M 22.85M 19.99M 20.95M 18.36M 18.54M 17.49M 15.78M 17.22M 14.8M 8.25M 6.84M 5.86M
Selling, General, and Administrative Revenue Growth +7.81% -0.61% -15.17% +4.18% +11.85% -3.98% -32.49% +13.83% +19.88% -5.25% -12.27% -2.54% -4.13% -1.77% +5.53% +33.65% -11.57% +27.54% -13.42% -17.02% +1.07% +18.46% -23.49% -12.88% +33.71% +21.75% +13.64% -0.59% -8.69% +14.29% -4.60% +14.13% -0.98% +6.00% +10.85% -8.36% +16.37% +79.36% +20.63% +16.79% n/a
Research and Development Revenue 2.28M 3.18M 4.46M 4.43M 4.61M 10.95M 13.56M 17.57M 13.82M 11.06M 25.55M 28.83M 42.07M 28.88M 28.59M 35.23M 38.12M 44.45M 49.18M 44M 36.89M 48.28M 34.71M 41.42M 42.97M 39.89M 30.42M 30.16M 39.56M 47.76M 28.84M 28.6M 33.38M 29.5M 30.24M 27.29M 16.09M 16.26M 14.24M 16.18M 14.5M
Research and Development Revenue Growth -28.29% -28.82% +0.74% -3.82% -57.92% -19.24% -22.84% +27.18% +24.96% -56.72% -11.41% -31.46% +45.69% +0.99% -18.84% -7.56% -14.26% -9.62% +11.77% +19.27% -23.58% +39.09% -16.21% -3.60% +7.72% +31.13% +0.87% -23.77% -17.16% +65.57% +0.86% -14.34% +13.15% -2.44% +10.83% +69.56% -1.05% +14.20% -11.96% +11.52% n/a
Sales and Marketing Revenue 12.31M 11.06M 10.97M 13.61M 11.44M 12.33M 12.96M 21.2M 21.15M 17.77M 18.38M 22.94M 23.42M 24.49M 25.21M 22.25M 15.24M 15.55M 12.52M 15.59M 20.2M 20.42M 16.98M 23.65M 28.72M 19.96M 16.28M 14.53M 13.84M 16.68M 13.53M 14.77M 11.62M 12.65M 12.16M 11.01M 11.85M 8.2M 4.12M 2.76M 2.27M
Sales and Marketing Revenue Growth +11.34% +0.77% -19.41% +18.98% -7.19% -4.85% -38.90% +0.24% +19.01% -3.28% -19.88% -2.07% -4.35% -2.85% +13.29% +46.04% -2.04% +24.27% -19.72% -22.81% -1.10% +20.28% -28.21% -17.66% +43.91% +22.58% +12.04% +5.03% -17.07% +23.31% -8.40% +27.12% -8.15% +4.04% +10.48% -7.15% +44.58% +98.84% +49.55% +21.51% n/a